Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.75
Bid: 45.50
Ask: 46.00
Change: 1.00 (2.19%)
Spread: 0.50 (1.099%)
Open: 45.00
High: 46.75
Low: 44.25
Prev. Close: 45.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 15th Apr 2021 14:56

Friday 16 April 
Ashmore Group PLCTrading Statement
Essentra PLCQ1 Results
Foxtons Group PLCTrading Statement
Mediclinic International PLCTrading Statement
Monday 19 April 
Churchill China PLCFull Year Results
Energean PLCFull Year Results
GB Group PLCTrading Statement
Tuesday 20 April 
Avast PLCQ1 Results
Associated British Foods PLCHalf Year Results
Card Factory PLCFull Year Results
City of London Investment Group PLCTrading Statement
Discoverie Group PLCTrading Statement
Filta Group Holdings PLCFull Year Results
Flowtech Fluidpower PLCFull Year Results
Jupiter Fund Management  PLCTrading Statement
MaxCyte IncFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Porvair PLCTrading Statement
RBG Holdings PLCFull Year Results
Rio Tinto PLCQ1 Operations Review
Wednesday 21 April 
Antofagasta PLCQ1 Production Results
BHP Group PLCQ1 Operations Review
Bunzl PLCQ1 Results
Carr's Group PLCHalf Year Results
Distribution Finance Capital Holdings PLCFull Year Results
Hochschild Mining PLCQ1 Production Results
Hunting PLCTrading Statement
Kier Group PLCHalf Year Results
Pennant International Group PLCFull Year Results
Polymetal International PLCQ1 Production Results
Quilter PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 22 April 
AJ Bell PLCTrading Statement
Anglo American PLCQ1 Production Results
Avacta Group PLCfull Year Results
BlackRock Greater Europe Investment Trust PLCHalf Year Results
Centamin PLCQ1 Production Results
Deltex Medical Group PLCFull Year Results
Domino's Pizza Group PLCTrading Statement
GB Group PLCTrading Statement
Gem Diamonds LtdTrading Statement
Ibstock PLCTrading Statement
Informa PLCFull Year Results
Jadestone Energy IncFull Year Results
Rentokil Initial PLCTrading Statement
RWS Holdings PLCTrading Statement
Segro PLCTrading Statement
Taylor Wimpey PLCTrading Statement
Trifast PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2021 11:16

Avacta confident despite filing delay for Covid-19 antigen test

(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group updated the market on its CE-mark submission for its 'AffiDX' SARS-CoV-2 antigen lateral flow test for professional use.

Read more
28 May 2021 11:29

Avacta still waiting on response from UK regulator over Covid test

Avacta still waiting on response from UK regulator over Covid test

Read more
28 May 2021 07:29

Avacta still waiting on MHRA approval for Covid-19 test

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group responded to speculation around the CE-mark submission for its SARS-CoV-2 antigen lateral flow test on Friday.

Read more
10 May 2021 11:13

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Read more
22 Apr 2021 12:17

Avacta sees Covid-19 tests driving earnings after reporting 2020 loss

Avacta sees Covid-19 tests driving earnings after reporting 2020 loss

Read more
20 Apr 2021 15:18

Avacta reports positive data for Covid-19 test product

(Sharecast News) - Diagnostics and cancer therapies developer Avacta announced positive data from the clinical validation of its 'AffiDX' SARS-CoV-2 antigen lateral flow test on Tuesday.

Read more
20 Apr 2021 12:17

IN BRIEF: Avacta's rapid Covid-19 test is 98% sensitive in trial

IN BRIEF: Avacta's rapid Covid-19 test is 98% sensitive in trial

Read more
20 Apr 2021 11:35

AIM WINNERS & LOSERS: Warpaint tops outlook; Avacta's Covid test works

AIM WINNERS & LOSERS: Warpaint tops outlook; Avacta's Covid test works

Read more
6 Apr 2021 13:53

IN BRIEF: Avacta in global Affimer distribution agreement with Abcam

IN BRIEF: Avacta in global Affimer distribution agreement with Abcam

Read more
6 Apr 2021 11:03

Avacta signs global distribution deal with Abcam

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a global distribution agreement with Abcam, it announced on Tuesday, to sell its recently-developed SARS-CoV-2 research 'ELISA Affimer' reagents.

Read more
25 Mar 2021 15:57

EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down

EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down

Read more
9 Mar 2021 20:19

IN BRIEF: Avacta Group signs diagnostic licensing deal with Biokit

IN BRIEF: Avacta Group signs diagnostic licensing deal with Biokit

Read more
9 Mar 2021 11:08

Avacta enters licence deal with Werfen subsidiary Biokit

(Sharecast News) - Cancer therapy and diagnostics developer Avacta has entered into a licence agreement with Werfen subsidiary Biokit, it announced on Tuesday, to incorporate 'Affimer' reagents into a Biokit in-vitro diagnostic product.

Read more
8 Mar 2021 19:07

IN BRIEF: Avacta's Covid antigen test confirmed to detect variants

IN BRIEF: Avacta's Covid antigen test confirmed to detect variants

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.